Faricimab versus Aflibercept for Discharge and Readmission in Neovascular Age-Related Macular Degeneration: A Lesion-Type Stratified, Real-World UK Analysis. [PDF]
Clin OphthalmolSingh Bhangu J +7 more
europepmc +1 more source
NICE-Informed Quality Improvement for Neovascular Age-Related Macular Degeneration: A Single-Centre Two-Cycle Audit of the Two-week Referral-to-Injection Standard. [PDF]
Clin OphthalmolTandon D +4 more
europepmc +1 more source
Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe. [PDF]
Medicina (Kaunas)Živković MLJ +4 more
europepmc +1 more source
Systemic cancer risk profile in neovascular age-related macular degeneration: insights into shared aging-related mechanisms from a nationwide population-based study. [PDF]
Aging (Albany NY)Kim HM, Bae Y, Kim M, Lee H, Chung H.
europepmc +1 more source
Short-term outcomes of intravitreal faricimab on refractory neovascular age-related macular degeneration patients in China. [PDF]
Front Med (Lausanne)Zhou F +6 more
europepmc +1 more source
Real-World Analysis of Switching Between Ranibizumab Biosimilars: Safety and Results - a Multicenter Retrospective Observational Study. [PDF]
Clin OphthalmolChakraborty D +7 more
europepmc +1 more source
Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit. [PDF]
CureusSukumaran D +8 more
europepmc +1 more source
Glucagon-Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence. [PDF]
Ophthalmol RetinaHallaj S +6 more
europepmc +1 more source
Preliminary Observations of Bilateral Neovascular Age-Related Macular Degeneration Progression: A Real-World Retrospective Case Series. [PDF]
J Clin MedTseng CH +4 more
europepmc +1 more source